Canada - English - Health Canada

pfizer canada ulc - dalteparin sodium - solution - 16500unit - dalteparin sodium 16500unit - heparins

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 5000 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism.unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu/ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections. cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dalteparin sodium - injection - 25000 iu/ml - dalteparin sodium 25000 iu/ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dalteparin sodium - injection - 10000 iu/ml - dalteparin sodium 10000 iu/ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dalteparin sodium - injection - 10000 iu/ml - dalteparin sodium 10000 iu/ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dalteparin sodium - injection - 2500 iu/0.2 ml - dalteparin sodium 2500 iu/0.2 ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dalteparin sodium - injection - 2500 iu/ml - dalteparin sodium 2500 iu/ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dalteparin sodium - injection - 5000 iu/0.2 ml - dalteparin sodium 5000 iu/0.2 ml